Skip to main content
. 2016 Jun 7;11(6):e0156677. doi: 10.1371/journal.pone.0156677

Table 1. Characteristics of the 972 culture-positive pulmonary tuberculosis patients included in this study, by diabetes and smoking.

Non-Diabetes Diabetes
Non smoker Smoker Non smoker Smoker
Total 365 149 284 174
Sex
 Male 202 (55.3%) 135 (90.6%) 170 (59.9%) 166 (95.4%)
 Female 163 (44.7%) 14 (9.4%) 114 (40.1%) 8 (4.6%)
Age (years)
 <45 124 (34.0%) 48 (32.2%) 22 (7.8%) 33 (19.0%)
 45–64 91 (24.9%) 62 (41.6%) 127 (44.7%) 101 (58.1%)
 ≥65 150 (41.1%) 39 (26.2%) 135 (47.5%) 40 (23.0%)
Case type
 New 312 (85.5%) 128 (85.9%) 243 (85.6%) 157 (90.2%)
 Retreatment 53 (14.5%) 21 (14.1%) 41 (14.4%) 17 (9.8%)
Smear
 Negative 171 (46.9%) 46 (30.9%) 93 (32.8%) 25 (14.4%)
 Positive 157 (43.0%) 96 (64.4%) 174 (61.3%) 134 (77.0%)
  Scanty 1 (0.3%) 1 (0.7%) 3 (1.1%) 4 (2.3%)
  1+ 47 (12.9%) 17 (11.4%) 38 (13.4%) 24 (13.8%)
  2+ 28 (7.7%) 24 (16.1%) 35 (12.3%) 22 (12.6%)
  3+ 26 (7.1%) 26 (17.5%) 47 (16.6%) 27 (15.5%)
  4+ 55 (15.1%) 28 (18.8%) 51 (18.0%) 57 (32.8%)
 Not done 37 (10.1%) 7 (4.7%) 17 (6.0%) 15 (8.6%)
DST pattern*
 Susceptible 265 (72.6%) 110 (73.8%) 210 (73.9%) 133 (76.4%)
 HrRs 23 (6.3%) 10 (6.7%) 19 (6.7%) 15 (8.2%)
 HrRr 12 (3.3%) 6 (4.0%) 14 (4.9%) 5 (2.9%)
 Other 7 (1.9%) 8 (5.4%) 8 (2.8%) 7 (4.0%)
 Not done 58 (15.9%) 15 (10.1%) 33 (11.6%) 14 (8.1%)

* DST, drug susceptibility testing; Susceptible, susceptible to isoniazid, rifampicin, ethambutol, and streptomycin; HrRs, any resistance to isoniazid but not resistance to rifampicin; HrRr, resistance to at least both isoniazid and rifampicin; Other, other resistant patterns.